Callan Family Office’s Incyte INCY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
11,538
+403
+4% +$40K 0.03% 522
2026
Q1
$1.05M Buy
11,135
+900
+9% +$89.8K 0.02% 548
2025
Q4
$1.01M Buy
10,235
+4,197
+70% +$406K 0.02% 544
2025
Q3
$512K Sell
6,038
-3,295
-35% -$260K 0.02% 523
2025
Q2
$636K Buy
+9,333
New +$591K 0.02% 513

Other funds holding INCY

Callan Family Office's INCY Position: Q2 2026 in Review

Callan Family Office increased its Incyte (INCY) stake by 3.6% in Q2 2026, buying an estimated $40K and bringing the position to 11,538 shares worth $1.31M. The position accounts for 0.03% of the portfolio, ranked #522.

Callan Family Office first reported a position in INCY in Q2 2025 and has held it in 5 quarters since. 861 funds tracked by Wall St. Rank hold INCY as of Q2 2026.

  • Callan Family Office held 11,538 shares of Incyte worth $1.31M as of Q2 2026.
  • Callan Family Office bought 403 Incyte shares in Q2 2026, an estimated $40K.
  • Incyte made up 0.03% of Callan Family Office's portfolio in Q2 2026, its #522 holding.
  • Callan Family Office first reported a position in Incyte in Q2 2025 and has held it in 5 quarters since.
  • 861 funds tracked by Wall St. Rank held Incyte as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.